Consolidated Statements of Operations [Abstract] | |
Net sales | |
Total cost of products sold | |
Gross margin | 46.57M |
Sales, general and administrative expenses | 28.12M |
Research and development expenses | 7.36M |
Litigation judgment expense | |
Loss on impairment | |
Loss on write down / disposal of property and equipment, net | |
Loss from operations | 11.09M |
Interest and other income, net | |
Loss before income tax benefit | |
Income tax benefit | 6.79M |
Net loss | 3.84M |
Loss per common and common equivalent shares | |
Basic | 0.07 |
Diluted | 0.07 |
Weighted average number of common and common equivalent shares outstanding | |
Basic | 52.21M |
Diluted | 53.14M |